[1] |
Miller N, Hernandez SG, Cleary TJ. Evaluation of gen-probe amplified Mycobacterium tuberculosis direct test and PCR for direct detection of Mycobacterium tuberculosis in clinical specimens. J Clin Microbiol, 1994, 32(2): 393-397. doi:10.1128/jcm.32.2.393-397.1994.
doi: 10.1128/jcm.32.2.393-397.1994
pmid: 8150948
|
[2] |
Ko DH, Lee EJ, Lee SK, et al. Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation. Ann Clin Microbiol Antimicrob, 2019, 18(1):2. doi:10.1186/s12941-018-0300-y.
doi: 10.1186/s12941-018-0300-y
|
[3] |
Guenaoui K, Harir N, Ouardi A, et al. Use of Genexpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases. Ann Transl Med, 2016, 4(9):168. doi:10.21037/atm.2016.05.09.
doi: 10.21037/atm.2016.05.09
pmid: 27275481
|
[4] |
Yan F, Wang W, Zhang J. CRISPR-Cas12 and Cas13: the lesser known siblings of CRISPR-Cas9. Cell Biol Toxicol, 2019, 35(6):489-492. doi:10.1007/s10565-019-09489-1.
doi: 10.1007/s10565-019-09489-1
pmid: 31468291
|
[5] |
Qiu E, Jin S, Xiao Z, et al. CRISPR-Based detection of Helicobacter pylori in stool samples. Helicobacter, 2021, 26(4): e12828. doi:10.1111/hel.12828.
doi: 10.1111/hel.12828
|
[6] |
Lei R, Li L, Wu P, et al. RPA/CRISPR/Cas12a-Based On-Site and Rapid Nucleic Acid Detection of Toxoplasma gondii in the Environment. ACS Synth Biol, 2022, 11(5): 1772-1781. doi:10.1021/acssynbio.1c00620.
doi: 10.1021/acssynbio.1c00620
URL
|
[7] |
Jiang C, Tao D, Geng Y, et al. Sensitive and Specific Detection of Lumpy Skin Disease Virus in Cattle by CRISPR-Cas12a Fluorescent Assay Coupled with Recombinase Polymerase Amplification. Genes (Basel), 2022, 13(5): 734. doi:10.3390/genes13050734.
doi: 10.3390/genes13050734
URL
|
[8] |
Li C, Lin N, Feng Z, et al. CRISPR/Cas12a Based Rapid Molecular Detection of Acute Hepatopancreatic Necrosis Disease in Shrimp. Front Vet Sci, 2021, 8:819681. doi:10.3389/fvets.2021.819681.
doi: 10.3389/fvets.2021.819681
|
[9] |
Xiao G, He X, Zhang S, et al. Cas12a/Guide RNA-Based Platform for Rapid and Accurate Identification of Major Mycobacterium Species. J Clin Microbiol, 2020, 58(2): e01368-19. doi:10.1128/jcm.01368-19.
doi: 10.1128/jcm.01368-19
|
[10] |
Gootenberg JS, Abudayyeh OO, Lee JW, et al. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science, 2017, 356(6336): 438-442. doi:10.1126/science.aam9321.
doi: 10.1126/science.aam9321
pmid: 28408723
|
[11] |
Kellner MJ, Koob JG, Gootenberg JS, et al. SHERLOCK: nucleic acid detection with CRISPR nucleases. Nat Protoc, 2019, 14(10): 2986-3012. doi:10.1038/s41596-019-0210-2.
doi: 10.1038/s41596-019-0210-2
pmid: 31548639
|
[12] |
Gootenberg JS, Abudayyeh OO, Kellner MJ, et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science, 2018, 360(6387): 439-444. doi:10.1126/science.aaq0179.
doi: 10.1126/science.aaq0179
pmid: 29449508
|
[13] |
East-Seletsky A, O’Connell MR, Knight SC, et al. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature, 2016, 538(7624):270-273. doi:10.1038/nature19802.
doi: 10.1038/nature19802
|
[14] |
Qin P, Park M, Alfson KJ, et al. Rapid and Fully Microfluidic Ebola Virus Detection with CRISPR-Cas13a. ACS Sens, 2019, 4(4): 1048-1054. doi:10.1021/acssensors.9b00239.
doi: 10.1021/acssensors.9b00239
URL
|
[15] |
Li Z, Wang M, Xu T, et al. Development and clinical implications of a novel CRISPR-based diagnostic test for pulmonary Aspergillus fumigatus infection. J Microbiol Immunol Infect, 2022, 55(4):749-756. doi:10.1016/j.jmii.2021.11.008.
doi: 10.1016/j.jmii.2021.11.008
URL
|
[16] |
Ai JW, Zhou X, Xu T, et al. CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis. Emerg Microbes Infect, 2019, 8(1):1361-1369. doi:10.1080/22221751.2019.1664939.
doi: 10.1080/22221751.2019.1664939
URL
|
[17] |
Abudayyeh OO, Gootenberg JS, Konermann S, et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 2016, 353(6299): aaf5573. doi:10.1126/science.aaf5573.
doi: 10.1126/science.aaf5573
URL
|
[18] |
Wang S, Li H, Kou Z, et al. Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system. Clin Microbiol Infect, 2021, 27(3):443-450. doi:10.1016/j.cmi.2020.04.018.
doi: 10.1016/j.cmi.2020.04.018
URL
|
[19] |
Hou T, Zeng W, Yang M, et al. Development and evaluation of a rapid CRISPR-based diagnostic for COVID-19. PLoS Pathog, 2020, 16(8):e1008705. doi:10.1371/journal.ppat.1008705.
doi: 10.1371/journal.ppat.1008705
|